Search Orphan Drug Designations and Approvals
-
Generic Name: | etoposide toniribate |
---|---|
Date Designated: | 02/11/2019 |
Orphan Designation: | Treatment of biliary tract cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CellAct Pharma GmbH Otto-Hahn str. 15 Dortmund 44227 Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-